Psychotropic Drug Use in Very Young Children

1998;148:1094-1102. 6. Update: influenza activity—United States and worldwide, 1998-99 season, and composition of the 1999-2000 influenza vaccine. MMRW Morb Mortal Wkly Rep. 1999;48:374-378. 7. Carr CM, Kim PS. Flu virus invasion: halfway there. Science. 1994;266:234236. 8. Holsinger, LJ, Nichani D, Pinto LH, Lamb RA. Influenza A virus M2 ion channel protein: a structure-function analysis. J Virol. 1994;68:1551-1563. 9. Kucers A, Crowe SM, Grayson ML, Hoy JF, eds. The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, and Antiviral Drugs. Oxford, England: Butterworth-Heinmann; 1997:1834-1854. 10. Wharton SA, Belshe RB, Skehel JJ, Hay AJ. Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine. J Gen Virol. 1994;75:945-948. 11. Monto AS, Arden NH. Implications of viral resistance to amantadine in control of influenza A. Clin Infect Dis. 1992;15:362-367. 12. Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med. 1989;321:1696-1702. 13. Laver WG, Bischofberger N, Webster RG. Disarming flu viruses. Sci Am. 1999; 280:78-87. 14. Monto AS, Fleming DM, Henry D, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis. 1999;180:254-261. 15. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA. 2000;283:1016-1024. 16. Barry AL. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in North America. Am J Med. 1999;107(suppl)(1A):28S-33S. 17. Nowak R. Hungary sees an improvement in penicillin resistance. Science. 1994; 264:364. 18. Stephenson J. Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria. JAMA. 1996;275:175. 19. Lui KJ, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health. 1987;77:7712-7716. 20. Stolberg SG. F.D.A. warns of overuse of 2 new drugs against flu. New York Times. January 13, 2000:A18. 21. Zimmerman RK. Lowering the age for routine influenza vaccination to 50 years: AAFP leads the nation in influenza vaccine policy. Am Fam Physician. 1999;60: 2061-2070. 22. Landry ML, Cohen S, Ferguson D. Impact of sample type on rapid detection of influenza virus A by cytospin-enhanced immunofluorescence and membranelinked immunosorbent assay. J Clin Microbiol. 2000;38:429-430.